InvenireX
3 known investors
InvenireX advances molecular diagnostics in life sciences through innovation in biotechnology. The company develops solutions for scientific research and healthcare applications.
Founders & leadership
D
DanFounder & CEO
Investors · 3
Also in the syndicate · 2
Cambridge Technology CapitalXTX Ventures
Funding
SEC filings, press & company announcements- Undisclosed amountseed fundingJan 2026
DSW Ventures (lead), Cambridge Technology Capital, XTX Ventures
Source ↗ - Undisclosed amountSeed fundingDec 2025Source ↗
- Undisclosed amountSeed FundingNov 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Companies House · registry record
View on Companies House ↗- Registered name
- INVENIREX LTD
- Company number
- 13819517
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 29 Dec 2021
- Registered office
- D1 Milburn House, Dean Street, Newcastle Upon Tyne, NE1 1LF
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 11 Aug 2026 · next due 25 Aug 2027
Current officers · 3
- Jane Theaker — director, appointed 24 Sept 2025
- Daniel Graham Todd — director, appointed 29 Dec 2021
- Josephine Elizabeth Todd — director, appointed 9 Jan 2024
Source: Companies House public register · retrieved 30 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does InvenireX do?
- InvenireX advances molecular diagnostics in life sciences through innovation in biotechnology. The company develops solutions for scientific research and healthcare applications.
- Who founded InvenireX?
- InvenireX was founded by Dan.
- Who are InvenireX's investors?
- InvenireX's investors include DSW Ventures.